RALEIGH, N.C., Nov. 16, 2010 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that the head of our Safety and Risk Management (SRM) group will speak at the 3rd annual China Drug Safety and Public Policy Summit being held in Shanghai 18-19 November 2010.
Dr. Sabine Richter, PRA's Vice President of SRM, will deliver the opening day's keynote address, "Challenges of Drug Safety in Global Clinical Trials." Her presentation will address the challenges and opportunities associated with handling safety data from global studies, including those in Asian countries. She will also review how cultural and regulatory factors affect the collection, reporting, and regulatory acceptance of safety data from trials performed outside of the United States and Europe.
Dr. Richter has over 20 years of research experience in the pharmaceutical and CRO industries, as well as in academia. Since joining PRA's SRM team in 2004, she has delivered numerous projects for a variety of clients and led large, long-term safety programs involving as many as 50 countries on five continents.
PRA's SRM group has more than 110 experts providing safety and risk management services throughout the entire product life cycle. Most SRM staff members are healthcare professionals (nurses, pharmacists, physicians) or life scientists. They offer consultancy as well as routine and specialty pharmacovigilance services. Our drug safety centers are based in Mannheim, Germany; Charlottesville, VA (US); and Sao Paulo, Brazil.
For more information about the conference, please visit www.prainternational.com and click on "Events."
About PRA International
PRA International conducts clinical trials in more than 85 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specializatio
|SOURCE PRA International|
Copyright©2010 PR Newswire.
All rights reserved